当前位置: 首页 >> 检索结果
共有 1964 条符合本次的查询结果, 用时 7.749853 秒

1. Effectiveness of an app-based walking program for obese patients with inflammatory bowel disease in Korea: a single-blind parallel-group randomized clinical trial.

作者: Young Jin Lee.;Eun Ja Kwon.;Da-In Park.;Sang Hyoung Park.;Sung Wook Hwang.;Byong Duk Ye.
来源: BMC Gastroenterol. 2025年25卷1期417页
Obesity in patients with inflammatory bowel disease (IBD) not only exacerbates symptoms but also interferes with treatment and leads to additional complications. Therefore, managing weight loss and preventing obesity are crucial. This study was designed to develop and implement a 10-week walking exercise program, facilitated by a mobile application, to evaluate its effectiveness in managing weight in obese IBD patients.

2. The effect of chewing gum on postoperative ileus after laparotomy for gastroduodenal perforations: a randomized controlled trial.

作者: Joshua Muhumuza.;Selamo F Molen.;Godefroy N Bassara.;Musa A Waziri.;Stephen M Kithinji.;Kiyaka M Sonye.;Mugisho M Leocadie.;ByaMungu P Kagenderezo.;Esperant T Tshimanga.;Tatana M Faustin.;Herman Lule.
来源: BMC Gastroenterol. 2025年25卷1期402页
Prolonged postoperative ileus is linked to a higher risk of additional complications, longer hospital stays, and higher healthcare expenses. There are few randomized controlled trials on the impact of chewing gum on the duration of ileus in patients undergoing emergency surgery, notably those with peritonitis. Compelling evidence from studies on elective procedures demonstrates that chewing gum can lessen the duration of ileus. This trial aimed to examine the effect of chewing gum on the length of the postoperative ileus which develop after laparotomy for gastroduodenal perforations.

3. Eradication of Helicobacter pylori that contributes to hepatogenic ulcer is beneficial to the healing of hepatogenic ulcer.

作者: Guanen Qiao.;Le Feng.;Meng Wang.;Chaoyang Wang.;Changjuan Li.;Shuxiang Han.;Yanmei Wang.;Shubo Li.;Shuanli Xin.
来源: BMC Gastroenterol. 2025年25卷1期359页
This study aimed to explore the role of Helicobacter pylori (Hp) eradication in patients with hepatogenic ulcer (HU).

4. A randomized, controlled trial of oral sulfate solution versus polyethylene glycol for bowel preparation for colonoscopy.

作者: Dong-Ling Xie.;Jin-Hui Fan.;Chan-Juan Fan.;Ying-Hui Gao.;Jian-Ping Cheng.
来源: BMC Gastroenterol. 2025年25卷1期292页
The quality of colonoscopy is significantly influenced by the effectiveness of bowel preparation. In this study, we aimed to evaluate the efficacy, safety, and tolerability of bowel cleansing between a new oral sulfate solution (OSS) and standard polyethylene glycol electrolyte powder (PEG).

5. Comparative effects of aerobic and resistance exercise on bile acid profiles and liver function in patients with non-alcoholic fatty liver disease.

作者: Jiasen Shi.;Junchao Cui.;Tianlei Zheng.;Xiaoping Han.;Bin Wang.;Wenjing Wang.;Chenggang Zhu.;Chenle Fang.;Xueyan Zhou.;Ning Cong.;Xiaoxing Yin.;Qiang Yang.
来源: BMC Gastroenterol. 2025年25卷1期239页
Our research aims to explore the effects of different exercise on liver function and bile acid in patients with non-alcoholic fatty liver disease (NAFLD), to identify the most beneficial exercise modalities for patients with NAFLD.

6. The impact of refined nursing management on the diagnosis of early gastric cancer under ME-NBI.

作者: Yi Fan.;Ming Ma.;Qing Liu.;Yu Wu.
来源: BMC Gastroenterol. 2025年25卷1期225页
To explore the impact of magnifying endoscopy with narrow-band imaging (ME-NBI) combined with refined nursing management on the endoscopic diagnosis of early gastric cancer.

7. A randomized open label pilot study evaluating the efficacy of two dosing regimens of rifamycin SV MMX in the treatment of small intestinal bacterial overgrowth.

作者: Bradley A Connor.;Marina Rogova.;Jefferson Garcia.;Morgan Gardner.;Charandeep Waraich.;Victoria Averill.
来源: BMC Gastroenterol. 2025年25卷1期219页
Antibiotics have demonstrated efficacy in the eradication of the underlying overgrowth bacteria and improvement of symptoms of small intestinal bacterial overgrowth (SIBO). The use of standard antibiotics may cause intolerable side effects such as development of multidrug-resistant enteric bacteria, Clostridioides difficile infections and dysbiosis. Nonabsorbable antibiotics have the advantage of minimized side effects. Rifaximin, an antibiotic of the ansamycin class has been shown to be effective in the treatment of SIBO. We evaluated the use of another ansamycin antibiotic, rifamycin SV MMX (AEMCOLO) in the treatment of SIBO. One difference from rifaximin is the site of delivery of AEMCOLO which appears to be the distal small intestine and colon. Hence by maintaining the microbial milieu of the proximal small intestine, the clearance of the overgrowth bacteria might be enhanced. The side effect profile of Rifamycin SV MMX has been described elsewhere in the pivotal trials; there were no safety signals noted in this study. This randomized open label pilot study evaluated the efficacy of two dosing regimens of AEMCOLO in treating SIBO. We used a simple randomization method to assign participants into study groups. The participants included 31 patients, split between two treatment arms: one receiving the medication twice daily and the other - three times daily. The outcomes were assessed based on symptom improvement and breath test normalization. The results indicated a beneficial response with both dosing regimens leading to symptom improvement and breath test normalization. Further evaluation revealed that in the three-time daily regimen, greater symptomatic improvement was observed. For clinicians treating SIBO, this study suggests that AEMCOLO is a viable treatment option. A double-blind, placebo-controlled design will probably be necessary to ascertain the true efficacy of different dosing regimens of AEMCOLO in treating SIBO.

8. A cost-effective measure to prevent hemorrhage in ultrasound-guided percutaneous liver biopsy.

作者: Qingyuan Cai.;Xiaomin Wu.
来源: BMC Gastroenterol. 2025年25卷1期178页
Liver biopsy is a procedure whereby a biopsy needle is used to extract tissue from the liver parenchyma or focal lesions of the liver for pathological or microbiological examination. Percutaneous liver biopsy(PC-LB) is the most commonly employed and least expensive modality. However, it is associated with a significant risk of bleeding complications, which may potentially result in patient mortality. The objective of this study was to investigate the efficacy of Absorbable Gelatin Sponge sheet filler agent (AGS-SFA) in preventing bleeding complications during liver tissue biopsy and to validate a cost-effective surgical technique.

9. A prospective randomized study of the efficacy of continuous active warming in patients undergoing laparoscopic gastrectomy.

作者: Mengjia Luo.;Yanran Dai.;Xiangying Feng.;Yujie Wang.;Xin Guo.;Juan Du.;Gang Ji.;Hongjuan Lang.
来源: BMC Gastroenterol. 2025年25卷1期174页
The RCT study on the efficacy of continuous active warming (CAW) in patients undergoing laparoscopic gastrectomy is scarce. The purpose of this research was to determine if a significant difference between continuous active warming (CAW) and active warming when body temperature is below 36 °C (BAW) in terms of incidence of intraoperative hypothermia and clinical rehabilitation in patients undergoing laparoscopic gastrectomy surgery.

10. Low-residue diet with oral nutritional supplements prior to colonoscopy improves the quality of bowel preparation: an endoscopist-blinded, randomized controlled trial.

作者: Huilin Shen.;Yijie Sun.;Jin Qian.;Jiaqi Wu.;Xueqing Zhong.;Guodong Li.;Weimin Li.
来源: BMC Gastroenterol. 2025年25卷1期166页
Poor bowel preparation has been a great problem of endoscopists for a long time. Low-residue diet (LRD) is often recommended on the day before colonoscopy. However, the quality of bowel preparation with LRD alone is suboptimal. The aim of our study was to examine whether patients who consumed LRD with oral nutritional supplements (ONSs) had higher quality of bowel preparation than patients who consumed LRD alone before colonoscopy.

11. Effect of montelukast on remission maintenance in patients with ulcerative colitis: a Randomized, double-blind controlled clinical trial.

作者: Kourosh Masnadi Shirazi.;Mehran Nezam Diba.;Arman Masnadi Shirazinezhad.;Zeinab Nikniaz.
来源: BMC Gastroenterol. 2025年25卷1期145页
Considering the role of leukotrienes in inflammatory pathways, and owing to the anti-leukotrienes effect of montelukast, in the present clinical trial, we aimed to assess the effect of montelukast on remission maintenance in patients with ulcerative colitis (UC).

12. The relationships between depression, inflammation and self-reported disease activity in IBD and their impact on healthcare usage.

作者: Natasha Seaton.;Vari Wileman.;Christine Norton.;Joanna Hudson.;Valeria Mondelli.;Rona Moss-Morris.
来源: BMC Gastroenterol. 2025年25卷1期140页
Depression is common in people living with Inflammatory Bowel Disease (IBD). Depression rates increase with active disease and are linked to poorer clinical outcomes. Previous studies investigating the relationship between contemporaneous IBD disease activity and depression are often poorly controlled, use small samples and/or rely on self-reported measures of disease activity. Depression and self-reported disease activity (SRDA) are linked to increased healthcare usage, however, objective inflammation is rarely statistically controlled. The primary aim was to understand how self-reported disease activity and inflammation are related to depression. Secondary aims included assessing the relative influence of self-reported disease activity, inflammation and depression on healthcare usage.

13. Operation sequence of bidirectional endoscopy with topical anesthesia affected colonoscopy performance: a randomized controlled trial.

作者: Qing Wang.;Yue Sui.;Jingwen Gong.;Xing Chen.
来源: BMC Gastroenterol. 2025年25卷1期121页
The operation sequence of bidirectional endoscopy with topical anesthesia varies among endoscopists, which interferes with clinical procedure. The study aimed to investigate the influence of different operation sequences on the outcomes of quality indicators and improve bidirectional endoscopy performance.

14. Pilot feasibility study to determine the utility of direct access and quantitative magnetic resonance cholangiopancreatography (MRCP) in the assessment of suspected acute biliary or ductal gallstone presentations.

作者: Alex Novak.;Anita Acharya.;Sally Beer.;Alexis Espinosa.;Giles Bond Smith.;Cyrene Saga.;Jane Andrews.;Adam Bailey.;Zahir Soonawalla.;Helen Bungay.;Michael Pavlides.
来源: BMC Gastroenterol. 2025年25卷1期72页
Patients with suspected acute gallstone disease typically undergo abdominal ultrasound. MRCP is often used for patients with abnormal LFTs, potentially making ultrasound unnecessary for this group. Despite high inter-reader variability in MRCP interpretation, new AI technologies may automate and standardize detection and measurement.

15. Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients.

作者: Qiyao Wei.;Jing Zhao.
来源: BMC Gastroenterol. 2025年25卷1期68页
To evaluate the therapeutic impact of reduced glutathione combined with entecavir on liver function, fibrosis, and HBV-DNA clearance in chronic hepatitis B patients.

16. Collagen turnover biomarkers to predict outcome of patients with biliary cancer.

作者: Leonard Kaps.;Muhammed A Genc.;Markus Moehler.;Stephan Grabbe.;Jörn M Schattenberg.;Detlef Schuppan.;Rasmus Sund Pedersen.;Morten A Karsdal.;Philipp Mildenberger.;Annett Maderer.;Nicholas Willumsen.
来源: BMC Gastroenterol. 2025年25卷1期53页
The collagen-rich tumor stroma plays a crucial role in biliary tract cancer (BTC). Collagen biomarkers of type I collagen (reC1M), type III collagen (PRO-C3), type IV collagen (C4G), type VIII collagen (PRO-C8), type XI collagen (PRO-C11), type XVII collagen (PRO-C17) and type VIII collagen (TUM) may be used as potential non-invasive biomarkers.

17. A Novel, IBS-Specific IgG ELISA-Based Elimination Diet in Irritable Bowel Syndrome: A Randomized, Sham-Controlled Trial.

作者: Prashant Singh.;William D Chey.;Will Takakura.;Brooks D Cash.;Brian E Lacy.;Eamonn M M Quigley.;Charles W Randall.;Anthony Lembo.
来源: Gastroenterology. 2025年168卷6期1128-1136.e4页
Personalized dietary therapies for irritable bowel syndrome (IBS) are needed and an immunoglobulin (Ig)G-antibody-based elimination diet presents a potential solution. However, existing studies have serious methodological limitations. This study aimed to assess the efficacy of an elimination diet by using a novel IBS-specific IgG assay.

18. Noncontrast Magnetic Resonance Imaging vs Ultrasonography for Hepatocellular Carcinoma Surveillance: A Randomized, Single-Center Trial.

作者: Hyungjin Rhee.;Myeong-Jin Kim.;Do Young Kim.;Chansik An.;Wonseok Kang.;Kyunghwa Han.;Yun Ho Roh.;Kwang-Hyub Han.;Sang Hoon Ahn.;Jin-Young Choi.;Jun Yong Park.;Yong Eun Chung.;Seung Up Kim.;Beom Kyung Kim.;Sunyoung Lee.;Hye Won Lee.;Jae Seung Lee.
来源: Gastroenterology. 2025年168卷6期1170-1177.e12页
This study aimed to compare ultrasonography (US) and noncontrast magnetic resonance imaging (MRI) in the surveillance of hepatic malignancy.

19. Glepaglutide, a Long-Acting Glucagon-like Peptide-2 Analogue, Reduces Parenteral Support in Patients With Short Bowel Syndrome: A Phase 3 Randomized Controlled Trial.

作者: Palle B Jeppesen.;Tim Vanuytsel.;Sukanya Subramanian.;Francisca Joly.;Geert Wanten.;Georg Lamprecht.;Marek Kunecki.;Farooq Rahman.;Thor S S Nielsen.;Mark Berner-Hansen.;Ulrich-Frank Pape.;David F Mercer.
来源: Gastroenterology. 2025年168卷4期701-713.e6页
Glepaglutide is a long-acting glucagon-like peptide (GLP)-2 analogue developed to improve intestinal absorption in patients with short bowel syndrome (SBS). The authors conducted a trial to establish the efficacy and safety of glepaglutide in reducing parenteral support (PS) needs in patients with SBS with intestinal failure.

20. Effect of an Endoscopy Screening on Upper Gastrointestinal Cancer Mortality: A Community-Based Multicenter Cluster Randomized Clinical Trial.

作者: Changfa Xia.;He Li.;Yongjie Xu.;Guizhou Guo.;Xiaodong Yu.;Wanying Wang.;Shuguang Dai.;Chunyun Dai.;Yigong Zhu.;Kun Jiang.;Zhiyi Zhang.;Junguo Hu.;Guohui Song.;Chao Chen.;Haifan Xiao.;Yanfang Chen.;Ting Song.;Shipeng Yan.;Bingbing Song.;Yutong He.;Jinyi Zhou.;Shaokai Zhang.;Wanqing Chen.
来源: Gastroenterology. 2025年168卷4期725-740页
Population-based observational studies suggest that endoscopic screening may reduce upper gastrointestinal cancer mortality. We aimed to quantify the effect of endoscopy screening.
共有 1964 条符合本次的查询结果, 用时 7.749853 秒